Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani

For PhRMA, supporting a move toward privatizing Medicare is a tactic that may help avoid the establishment of new price controls in the system, like the often-discussed mandated drug rebates in Part D.